Technology appraisal programme of the National Institute for Clinical Excellence: a review by WHO: June–July 2003

Simple item page
dc.coverageCopenhagen
dc.creatorHill, Suzanne
dc.creatorGarattini, Silvio
dc.creatorLoenhout, Jos van
dc.creatorO'Brien, Bernie J
dc.creatorDe Joncheere, Kees
dc.date2014-03-19T23:03:03Z
dc.date2014-03-19T23:03:03Z
dc.date2003
dc.date2003-12-31
dc.date.accessioned2026-08-03T10:46:51Z
dc.description51 p.
dc.descriptionThe National Institute of Clinical Excellence (NICE) is responsible for providing guidance to the National Health Service in England and Wales on the clinical- and cost-effectiveness of medicines and medical technologies. After a review of the Institute by the House of Commons Health Select Committee in 2002, NICE commissioned a series of internal reviews on their work, and requested the WHO Regional Office for Europe to carry out an external review on their methods and processes as well as their scientific robustness. The WHO team of experts based their report on the review of a series of technology appraisals, including confidential material, and extensive discussions with NICE staff, Appraisal Committee members, members of the Technical Assessment Groups and other stakeholders during the course of two visits to NICE in summer 2003. The report contains a series of recommendations on how NICE could further develop the technology appraisal process. As NICE is internationally a leading agency in technology assessment, the important recommendations and observations contained in the report will be useful to other countries that are embarking on similar endeavours
dc.formatapplication/pdf
dc.identifierEUR/03/5045738
dc.identifierWHO/EURO:2003-8585-48357-71795
dc.identifierhttps://iris.who.int/handle/10665/107504
dc.identifier.urihttps://repo.dare.co.zw/handle/123456789/240847
dc.languageEnglish
dc.languageen
dc.publisherWorld Health Organization. Regional Office for Europe
dc.rightsWorld Health Organization
dc.subjectTechnology Assessment, Biomedical
dc.subjectPharmaceutical Preparations
dc.subjectCost-Benefit Analysis
dc.subjectEconomics, Pharmaceutical
dc.subjectEvaluation Studies
dc.subjectEvidence-Based Medicine
dc.subjectUnited Kingdom
dc.subjectEurope
dc.subjectPharmaceuticals and Biologicals
dc.subjectstandards
dc.titleTechnology appraisal programme of the National Institute for Clinical Excellence: a review by WHO: June–July 2003
dc.typeTechnical Documents

Files

Collections

WHO IRIS